A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of LRK-4189 Alone and in Combination in Patients With Solid Tumors
LARKSPUR BIOSCIENCES, INC.
LARKSPUR BIOSCIENCES, INC.
Hoffmann-La Roche
Shanghai JMT-Bio Inc.
Immunocore Ltd
Akeso
Merus B.V.
Syndax Pharmaceuticals
Krystal Biotech, Inc.
Alligator Bioscience AB
Incyte Corporation
Akeso
Ability Pharmaceuticals SL
Myeloid Therapeutics
Guangzhou Gloria Biosciences Co., Ltd.
Genelux Corporation
Immunicom Inc
Ningbo Cancer Hospital
Ningbo Cancer Hospital
Shanghai International Medical Center
Shanghai International Medical Center
Pfizer
Novacea
FeRx